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Abstract
Background:  Identifying  persons  at  high  risk  for  advanced  colorectal  neoplasia  can  aid  in  the
prevention  of  colon  cancer.  Previous  studies  have  shown  that  some  patients  can  present  with
proximal advanced  neoplasia  with  no  distal  ﬁndings.
Aims:  To  determine  the  factors  related  to  advanced  neoplasia  and  advanced  proximal  colorectal
neoplasia  in  a  Latin  American  population.
Material  and  methods:  A  prospective,  cross-sectional,  observational,  analytic  study  was  con-
ducted. It  included  patients  that  underwent  colonoscopy  at  the  Policlínico  Peruano  Japonés
within the  time  frame  of  January  and  July  2012.  Advanced  neoplasia  was  deﬁned  as  the  pres-
ence of  lesions  ≥  10  mm  with  a  villous  component,  high-grade  dysplasia,  or  carcinoma.  The
splenic ﬂexure  was  the  limit  between  the  proximal  and  distal  colon.
Results:  A  total  of  846  patients  were  included  in  the  study.  Advanced  neoplasia  was  detected
in 108  patients  (12.8%)  and  advanced  proximal  neoplasia  in  55  patients  (6.7%),  42  (76.4%)  of
whom had  no  neoplasia  in  the  distal  colon.  Factors  related  to  advanced  neoplasia  found  in
the multivariate  analysis  were  age,  at  the  intervals  of  50-59  (p  =  0.019),  60-69  (p  =  0.016),  and
≥ 70  years  (0.002)  and  male  sex  (p  =  0.003).  In  the  evaluation  of  advanced  proximal  neoplasia,
the multivariate  analysis  identiﬁed  the  60-69  year  age  interval  (p  =  0.039)  and  advanced  distal
neoplasia (p  =  0.028)  as  factors  related  to  advanced  proximal  disease.  The  ROC  curve  established
the age  cut-off  point  at  60  years  for  initially  performing  colonoscopy,  rather  than  sigmoidoscopy.
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Conclusions:  Age  and  sex  are  related  to  advanced  neoplasia,  whereas  age  and  advanced  distal
neoplasia  are  related  to  advanced  proximal  neoplasia.
© 2015  Asociación  Mexicana  de  Gastroenterología.  Published  by  Masson  Doyma  México  S.A.
This is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Factores  relacionados  a  neoplasia  avanzada  colorrectal  en  el  Policlínico  Peruano
Japonés
Resumen
Antecedentes:  Identiﬁcar  personas  con  alto  riesgo  de  neoplasia  avanzada  colorrectal  puede
ayudar en  la  prevención  de  cáncer  de  colon.  Por  otro  lado,  estudios  previos  han  observado  que
algunos pacientes  pueden  tener  neoplasia  avanzada  proximal  sin  hallazgos  distales.
Objetivo:  Determinar  los  factores  relacionados  a  neoplasia  avanzada  y  neoplasia  avanzada
proximal colorrectal  en  una  población  latinoamericana.
Material  y  métodos:  Estudio  analítico,  observacional,  transversal  y  prospectivo.  Se  incluyó  a
pacientes sometidos  a  colonoscopia  en  el  Policlínico  Peruano  Japonés  entre  enero  y  julio  del
2012. Se  deﬁnió  neoplasia  avanzada  como  la  presencia  de  lesiones  ≥  10  mm  en  taman˜o,  con
componente  velloso  o  displasia  de  alto  grado  o  carcinoma.  El  límite  entre  el  colon  proximal  y
distal fue  el  ángulo  esplénico.
Resultados:  Se  incluyó  a  846  pacientes.  Se  detectó  neoplasia  avanzada  en  108  pacientes
(12.8%). Se  detectó  neoplasia  avanzada  proximal  en  55  pacientes  (6.7%),  de  los  cuales  42
(76.4%) tuvieron  el  colon  distal  sin  neoplasias.  El  análisis  multivariado  encontró  como  factores
relacionados  a  neoplasia  avanzada  a  la  edad,  en  intervalos  50-59  (p  =  0.019),  60-69  (p  =  0.016)
y ≥  70  an˜os  (0.002)  y  el  género  masculino  (p  =  0.003).  Al  evaluar  neoplasia  avanzada  proximal,
el análisis  multivariado  encontró  a  la  edad  en  intervalo  de  60-69  an˜os  (p  =  0.039)  y  la  neoplasia
avanzada distal  (p  =  0.028)  como  relacionados.  La  curva  ROC  estableció  un  corte  de  edad  de
60 an˜os  para  realizar  colonoscopia  de  inicio  en  lugar  de  sigmoidoscopia.
Conclusiones:  La  edad  y  el  género  están  relacionados  con  neoplasia  avanzada,  mientras  que  la
edad y  la  neoplasia  avanzada  distal  están  relacionadas  a  neoplasia  avanzada  proximal
© 2015  Asociación  Mexicana  de  Gastroenterología.  Publicado  por  Masson  Doyma  México  S.A.
Este es  un  artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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olorectal  cancer  is  the  third  most  common  cancer  in
en  and  the  second  most  common  in  women  worldwide,
ith  more  than  1.2  million  new  cases  and  more  than
00,000  deaths  annually.1
Colorectal  cancer  screening  in  the  general  population  can
educe  the  colorectal  cancer  mortality  rate.  The  interna-
ional  guidelines  recommend  this  screening  from  the  age
f  50  years,  through  tests  such  as  fecal  occult  blood,
igmoidoscopy,  and  colonoscopy.2 However,  these  recom-
endations  are  not  always  observed.  One  of  the  main
arriers  to  screening  is  the  lack  of  risk  perceived  by  the
atients  and  even  by  the  primary  care  physicians.3,4 The
isk  for  colorectal  cancer  or  advanced  neoplasia  (AN)  in  gen-
ral,  varies  according  to  several  factors,  including  age,5--9
ex,6--10 a  family  history  of  colon  cancer,6,8,9,11 tobacco
moking,8,9,12,13 obesity,7,9,14 diabetes  mellitus,15 etc.  Infor-
ation  on  these  factors  is  easy  to  obtain  and  could  be  used  to
dentify  those  patients  at  high  risk  for  AN  that  would  beneﬁt
ost  from  screening.
p
P
sFlexible  sigmoidoscopy  is  a  simple  screening  method  for
olorectal  cancer.  Not  only  does  it  reduce  the  incidence
f  colorectal  cancer,  but  it  reduces  the  mortality  rate,  as
ell.  A  large  randomized  study  reported  that  sigmoidoscopy
lone,  performed  in  patients  between  the  ages  of  55  and
4  years,  reduced  the  incidence  of  colorectal  cancer  by  33%
nd  the  colorectal  cancer  mortality  rate  by  43%  during  a
ean  11.2-year  follow-up  period.16 The  addition  of  a  yearly
ecal  occult  blood  test  to  sigmoidoscopy  has  been  reported
o  have  little  or  no  beneﬁt.17,18 To  the  contrary,  it  can  reduce
creening  participation.19,20
Nevertheless,  despite  the  strong  evidence  of  the  clinical
eneﬁts  of  sigmoidoscopy,  this  procedure  does  not  enable
roximal  colon  evaluation.  A  complementary  colonoscopy
ust  be  performed  if  the  sigmoidoscopy  result  indicates
he  presence  of  distal  neoplasia,  especially  if  it  is  greater
han  1  cm,  if  it  has  a  villous  histology,  or  if  there  are
ultiple  neoplasia,  given  that  these  are  risk  factors  for
roximal  advanced  neoplasia  (PAN).5,21--27 The  prevalence  of
AN  varies  between  1.7  and  5.4%,  according  to  published
tudies.5,22,23,27,28 However,  60  to  70%  of  the  patients  with
clíni
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the  patient  had  more  than  one  lesion,  whether  in  the  prox-
imal  or  distal  colon,  the  more  advanced  lesion  was  the  one
classiﬁed.
Table  1  Types  of  colonic  neoplasia  ﬁndings  in  the
colonoscopies.
Colonic  neoplasia  No.  %
Adenoma  223  26.4Factors  related  to  advanced  colorectal  neoplasm  at  the  Poli
PAN  do  not  present  with  distal  neoplasia.5,22,29--31 Therefore,
these  patients  with  PAN  could  go  undetected  if  colonoscopy
is  performed  based  solely  on  the  previous  sigmoidoscopy
ﬁndings.  Ideally,  proximal  colon  examination  should  be
selectively  carried  out  on  patients  at  high  risk  for  PAN,  based
on  a  stronger  predictive  model  that  includes  sigmoidoscopy
ﬁndings  and  clinical  risk  factors.  However,  there  have  been
few  studies  on  this  subject.21,23,25,29,30,32,33 The  aim  of  our
study  was  to  determine  the  factors  related  to  colorectal  AN
and  PAN.
Methods
This  is  an  analytic,  observational,  cross-sectional,  prospec-
tive  study  and  was  approved  by  the  Ofﬁce  of  Training,
Research  and  Teaching  of  the  Policlínico  Peruano  Japonés.
It  included  all  the  outpatients  that  underwent  colonoscopy
at  the  Gastroenterology  Service  of  the  Policlínico  Peruano
Japonés  within  the  time  frame  of  January  to  July  2012.  The
Policlínico  Peruano  Japonés  is  a  private  institution  and  the
majority  of  its  patients  are  outpatients.  A  total  of  14  expe-
rienced  gastroenterologists  performed  the  procedures.  The
colonoscopies  were  carried  out  with  Olympus  equipment,
models  CF-H  180,  CF-Q  160  ZL,  CF-H  150,  and  CF-Q  150
and  Fujinon  equipment,  model  EC-590  WL.  All  the  proce-
dures  were  recorded  and  archived.  Patients  under  the  age
of  16  years  and  those  that  did  not  have  an  anatomopatho-
logic  study  were  excluded.  All  the  patients  received  verbal
and  written  instructions  for  intestinal  preparation  and  the
divided  dose  system  was  used  for  all  the  procedures.  The
colon  cleansing  preparations  used  were  polyethylene  gly-
col  (PEG)  in  its  presentation  of  envelopes  containing  105  g
of  PEG  3350  and  sodium  phosphate  (in  45  ml  bottles  that
contained  48  g  of  monobasic  sodium  phosphate  and  18  g  of
dibasic  sodium  phosphate  per  each  100  ml).  If  the  exam-
ination  was  to  be  performed  in  the  morning,  the  patient
was  instructed  to  take  3  PEG  envelopes  the  night  before
and  one  in  the  morning,  or  one  bottle  of  sodium  phosphate
the  night  before  and  another  in  the  morning.  If  the  exam-
ination  was  in  the  afternoon,  the  patient  was  instructed
to  take  2  PEG  envelopes  the  night  before  and  2  envelopes
the  morning  of  the  exam  or  one  bottle  of  sodium  phos-
phate  the  night  before  and  another  bottle  the  morning  of
the  exam.
Before  the  procedure,  the  patients  were  interviewed  and
the  following  information  was  collected:
1.  Demographic  data:  age,  sex,  weight,  height,  body  mass
index  (BMI),  and  educational  level.
2.  Personal  medical  history,  including  past  medical  history
(diabetes  mellitus,  cerebrovascular  disorder,  cirrhosis,
antidepressive/anti-anxiety  drug  use,  current  tobacco
smoker,  number  of  bowel  movements  per  week,  abdom-
inal  surgery,  a  history  of  prior  colonoscopy,  polyps,  or
colon  cancer,  and  a  family  history  of  colon  cancer).
3.  Colonoscopy  indication:  for  diagnostic  purposes  (patient
with  symptoms  such  as  abdominal  pain,  hematochezia,
rectorrhagia,  chronic  diarrhea,  constipation,  or  anemia
in  study),  screening  or  follow-up  (post-polypectomy  or
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.  Bowel  preparation  characteristics:  the  use  of  PEG  or
sodium  phosphate  and  the  addition  of  a laxative.
.  Adverse  effects  experienced  during  the  preparation:
nausea,  vomiting,  abdominal  pain,  bloating,  anal
irritation,  or  sleep  disorder.
Data  on  the  following  colonoscopy-related  variables  were
ollected  during  the  procedure:  the  time  at  which  the  study
as  begun,  withdrawal  time,  ﬁndings,  and  bowel  prepa-
ation  quality.  The  time  of  colonoscopy  was  classiﬁed  as
‘morning’’  if  it  was  performed  between  08:00  am  and
1:59  am  or  ‘‘afternoon’’  if  it  was  performed  between  12:00
m  and  06:00  pm.  Bowel  preparation  quality  was  registered
y  the  endoscopist  in  charge  of  the  procedure  and  cate-
orized  as  excellent  (adequate  visualization  of  the  entire
olon  with  no  washout  or  suction),  good  (adequate  visu-
lization  of  more  than  90%  of  the  colon  with  clear  ﬂuids
equiring  minimum  suction  and  minimum  or  no  washout),
egular  (unsatisfactory  visualization  of  all  or  part  or  the
olon  with  dark  ﬂuid  and  liquid  feces  that  required  suction
nd  washout),  and  poor  (unsatisfactory  visualization  of  all
r  part  of  the  colon,  with  dark  ﬂuid  and  feces  requiring  suc-
ion  and  washout  and  the  need  to  consider  re-examination)
ased  on  the  predeﬁned  Aronchick  scale.34,35 For  the
urposes  of  our  study  we  redeﬁned  the  level  of  prepara-
ion  as  ‘‘optimum’’  (excellent  or  good)  or  ‘‘suboptimum’’
regular  or  poor).  If  elevated  lesions  were  found,  the  cor-
esponding  histopathologic  report  was  obtained  after  the
rocedure.
Conventional  colonoscopy  was  performed  by  experienced
astroenterologists.  Complete  colonoscopy  was  considered
hen  the  colonoscope  reached  the  cecum.  During  the
olonoscopy,  the  location  and  size  of  all  the  polyps  were
etermined  before  their  removal.  Size  was  measured  com-
aring  the  lesion  with  the  open  biopsy  forceps  or  based  on
linical  judgment.  Lesion  location  was  determined  by  the
linical  judgment  of  the  gastroenterologist.
The  splenic  ﬂexure  was  established  as  the  limit  between
he  proximal  and  distal  colon.22,23,29,31,36,37 The  deﬁnition
f  AN  was  the  presence  of  lesions  larger  than  10  mm
ith  a  villous  component  or  with  high-grade  dysplasia
r  carcinoma.8,23,29,37 Cancer  was  deﬁned  as  the  invasion
f  malignant  cells  under  the  muscularis  mucosae.31 For
urposes  of  the  analysis,  traditional  serrated  adenomas,
errated  sessile  lesions,  and  mixed  serrated  polyps  were  cat-
gorized  as  tubular  adenomas.9 Polyps  under  10  mm  that
ere  not  extirpated,  were  regarded  as  non-neoplastic.9 IfAN 108  12.8
Cancer 20  2.4
AN: advanced neoplasia.
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Data  were  reported  as  absolute  and  relative  frequencies
or  discrete  or  nominal  variables,  and  as  means,  standard
eviation  (SD),  and  range  for  the  continuous  variables.  These
ata  were  analyzed  using  the  SPSS  version  16.0  statisti-
al  package  and  the  tables  were  constructed  using  the
xcel  program.  The  variables  were  crossed  by  means  of  2  x
 tables.  Each  variable  was  studied  for  its  association  with
he  presence  of  AN  and  PAN.  The  chi-square  test  or  Fisher
xact  test  were  used  for  the  categorical  variables  and  the
a
r
e
Table  2  Factors  related  to  the  univariate  analysis-AN.
Characteristics  Patient  total  No.  =  84
Age,  years  ±  SD  57.67  ±  14.77  
Age,  n  (%)  
<  40  102  (12.1)  
40-49 138  (16.3)  
50-59 199  (23.5)  
60-69 213  (25.2)  
≥ 70  194  (22.9)  
Sex, n  (%)
Men  297  (35.1)  
Women  549  (64.9)  
BMI, mean  ±  SD  26.02  ±  4.02  
BMI  ≥  30,  n  (%)  119  (14.1)  
BMI  <  30,  n  (%)  727  (85.9)  
Time of  the  examination,  n  (%)
‘‘Morning’’  350  (41.4)  
‘‘Afternoon’’  496  (58.6)  
Current tobacco  smoking,  n  (%) 330  (39.0)
Personal  history  of  polyps,  n  (%) 101  (11.9)
Previous  colonoscopy,  n  (%)  291  (34.4)  
Family  history  of  colon  cancer,  n  (%)  112  (13.2)  
Diabetes  Mellitus,  n  (%)  62  (7.3)  
Bowel  movements  per  week,  n  (%)
1-3  67  (7.9)  
4-6  155  (18.3)  
7 or  more  624  (73.8)  
Enema received,  n  (%)
Polyethylene  glycol  770  (91.0)  
Sodium  phosphate  76  (9.0)  
Quality of  bowel  preparation,  n  (%)
Optimum  405  (47.9)  
Suboptimum  441  (52.1)  
Colonoscopy  indication,  n  (%)
Diagnostic  500  (59.1)  
Screening  257  (30.4)  
Follow-up 89  (10.5)  
AN: advanced neoplasia; SD: standard deviation.
a Chi-square test with the Yates correction.
b Pearson chi-square test.
c Mann-Whitney U test.V.  Parra-Pérez  et  al.
ann-Whitney  U  test  was  used  for  the  continuous  variables.
ge  was  evaluated  as  a  continuous  and  categorical  variable
<  40,  40-49,  50-59,  60-69,  and  ≥  70).  BMI  was  categorized  as
 30  (obese)  and  <  30  (not  obese).  The  variables  that  were
igniﬁcantly  associated  with  AN  and  PAN  in  the  univariate
nalysis  then  underwent  multivariate  analysis  using  logistic
egression.
The  patients  that  had  incomplete  colonoscopy  were
xcluded  from  the  analysis  of  risk  factors  for  PAN.
6 AN
Yes  No  p
63.69  ±  13.20  56.79  ±  14.79  0.000c
0.002b
5  (4.6)  97  (13.1)
9  (8.3)  129  (17.5)
28  (25.9)  171  (23.2)
30  (27.8)  183  (24.8)
36  (33.4)  158  (21.4)
50  (46.3)  247  (33.5)  0.012a
58  (53.7)  491  (66.5)
26.13  ±  3.75  26.00  ±  4.06  0.629c
15  (13.9)  104  (14.1)  1.000a
93  (86.1)  634  (85.9)
43  (39.8)  307  (41.6)  0.805a
65  (60.2)  431  (58.4)
51  (47.2) 279  (37.8) 0.077a
14  (13.0) 87  (11.8)  0.847a
36  (33.3)  255  (34.6)  0.888a
19  (17.6)  93  (12.6)  0.201a
9  (8.3)  53  (7.2)  0.817a
6  (5.6)  61  (8.3)  0.620b
20  (18.5)  135  (18.3)
82  (75.9)  542  (73.4)
98  (90.7)  672  (91.1)  1.000a
10  (9.3)  66  (8.9)
47  (43.5)  358  (48.5)  0.386a
61  (56.5)  380  (51.5)
61  (56.5)  439  (59.5)  0.297b
31  (28.7)  226  (30.6)
16  (14.8)  73  (9.9)
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Table  3  Factors  related  to  the  multivariate  analysis-AN.
OR  95%  CI  p
Age,  years
<  40  1.000  -  -
40-49  1.283  0.415-3.964  0.665
50-59  3.264  1.216-8.758  0.019
60-69  3.330  1.247-8.890  0.016
≥ 70  4.698  1.775-12.436  0.002
Sex
Men  1.898  1.252-2.878  0.003
Women 1.000 -  -
60
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0.2
0.0
0.0
ROC area under the curve=0.621 (0.552-0.690)
Sensitivity (95% CI)=61.82% (48.98-74.66)
Specificity (95% CI)=53.59% (50.00-57.11)
Positive Predictive Value=8.72% (5.92-11.52)
Negative Predictive Value=95.14% (93.11-97.17)
Figure  1  ROC  curve  deﬁning  an  optimal  age  cut-off  point  for
distinguishing  patients  requiring  initial  colonoscopy  based  on
risk for  PAN.  The  area  under  the  curve,  sensitivity,  speciﬁcity,
and positive  and  negative  predictive  values  are  shown,
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DiscussionAN: advanced neoplasia.
Results
A  total  of  846  colonoscopies  that  ﬁt  the  inclusion  criteria
were  performed  during  the  study  period.  The  mean  age  was
57.67  years  (SD  ±  14.77),  71.6%  of  the  patients  were  above
50  years  of  age,  and  64.9%  were  women.  A  total  of  119
(14.1%)  of  the  patients  were  obese  (BMI  ≥  30).  The  most
frequent  indication  for  the  examination  was  for  diagnostic
purposes  (59.1%).  A  total  of  112  (13.2%)  patients  had  a  fam-
ily  history  of  colon  cancer  and  291  (34.4%)  had  undergone
previous  colonoscopy.  Of  the  846  colonoscopies  performed,
the  cecum  was  reached  in  822  (97.1%).  In  54.1%  of  the  colo-
noscopies,  the  withdrawal  time  was  greater  than  or  equal
to  6  min.  In  6  colonoscopies,  polyps  under  10  mm  that  had
a  hyperplastic  aspect  and  were  located  in  the  rectum  were
not  removed  at  the  discretion  of  the  endoscopist.
Some  type  of  colonic  neoplasia  was  detected  during
colonoscopy  in  243  (28.7%)  patients,  223  (26.4%)  of  which
corresponded  to  adenomas  and  20  (2.4%)  to  cancer.  A  total
of  108  (12.8%)  patients  presented  with  AN  (table  1).
Factors  related  to  AN  through  the  univariate  analysis  in
the  total  number  of  patients  were  age  (p  =  0.002)  and  male
sex  (p  =  0.012)  (table  2).
The  multivariate  analysis  conﬁrmed  a  statistically  sig-
niﬁcant  associationThe  multivariate  analysis  conﬁrmed  a
statistically  signiﬁcant  association  of  age  in  the  ranges  of
50-59  (p  =  0.019),  60-69  (p  =  0.016),  and  ≥  70  years  (p  =
0.002),  as  well  as  in  the  male  sex  (p  =  0.003)  (table  3)  with
AN.Of  the  822  patients  that  had  complete  examination  of
the  colon,  99  (12.0%)  presented  with  AN.  Of  those  patients,
55  presented  with  PAN.  Of  the  PAN  group,  42  (76.4%)  had  no
O
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Table  4  Risk  for  PAN  according  to  distal  ﬁndings  (n  =  822).
Distal  ﬁndings  No.  of  p
No  distal  neoplasia  692  
1-2 distal  non-advanced  neoplasias  73  
≥ 3  distal  non-advanced  neoplasias  or  some  distal  AN  57  
Distal AN  52  
AN: advanced neoplasia; PAN: proximal advanced neoplasia.I: conﬁdence  interval.
eoplastic  lesion  in  the  distal  colon.  Despite  this  fact,  ﬁnd-
ngs  in  the  distal  colon  can  predict  the  presence  of  PAN  (table
).  The  presence  of  ≥  3  distal  non-advanced  neoplasias  or
istal  AN  increased  the  risk  for  PAN  almost  2.5-fold.  The  uni-
ariate  analysis  found  age  (p  =  0.047)  and  the  presence  of
istal  AN  (p  =  0.018)  as  signiﬁcant  factors  related  to  the  pres-
nce  of  PAN  (table  5).  The  multivariate  analysis  conﬁrmed
he  signiﬁcant  association  of  age  at  the  interval  of  60-69
ears  (p  = 0.039)  and  the  presence  of  distal  AN  (p=0.028),
ith  the  presence  of  PAN  (table  6).  The  ROC  curve  gener-
ted  from  age  and  the  presence  of  PAN  (ﬁg.  1)  showed  an
rea  under  the  curve  of  0.621  and  the  cut-off  point  of  60
ears  was  the  one  that  best  distinguished  the  need  for  initial
olonoscopy  rather  than  sigmoidoscopy.ur  study  conﬁrmed  the  results  of  previous  analyses  that
howed  age  and  male  sex  as  factors  associated  with  AN.
atients  PAN  =  55  OR  (95%  CI)
No.  of  patients  %
42  6.1  Reference
5  6.8  1.028  (0.397-2.664)
8  14.0  2.494  (1.117-5.570)
8  15.4  2.797  (1.245-6.281)
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We  preferred  to  evaluate  AN  rather  than  cancer,  given
hat  previous  studies  suggested  that  this  was  a  more  ade-
uate  aim  in  relation  to  colonoscopy  screening.5--10,13,28
evertheless,  some  predictive  models  exclusively  for
ancer38--40 have  previously  been  developed  and  both  cancer
nd  AN  are  important  study  aims  for  colon  cancer  screening
hat  will  enable  the  colorectal  cancer  mortality  rate  to  be
educed.  Early  colorectal  cancer  detection  and  treatment
f
h
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Table  5  Factors  related  to  the  univariate  analysis-PAN.
Characteristics  Patients  with  cecal  intub
Age,  years  ±  SD  57.39  ±  14.67  
Age,  n  (%)  
<  40  101  (12.3)  
40-49 136  (16.5)  
50-59 195  (23.7)  
60-69 208  (25.3)  
≥ 70  182  (22.1)  
Sex, n  (%)
Women  532  (64.7)  
Men  290  (35.3)  
BMI mean  ±  SD 26.02  ±  3.99  
BMI  ≥  30,  n  (%) 114  (13.9)
BMI  <  30,  n  (%) 708  (86.1)  
Time of  the  examination,  n  (%)
‘‘Morning’’  342  (41.6)  
‘‘Afternoon’’  480  (58.4)  
Current tobacco  smoking,  n  (%)  317  (38.6)  
Personal  history  of  polyps,  n  (%)  100  (12.2)  
Previous  colonoscopy,  n  (%)  284  (34.5)  
Family  history  of  colon  cancer,  n  (%)  109  (13.3)  
Diabetes  mellitus,  n  (%)  58  (7.1)  
Bowel  movements  per  week,  n  (%)
1-3  66  (8.0)  
4-6  153  (18.6)  
7 or  more  603  (73.4)  
Enema received,  n  (%)
Polyethylene  glycol  750  (91.2)  
Sodium  phosphate  72  (8.8)  
Quality of  bowel  preparation,  n  (%)
Optimum  395  (48.1)  
Suboptimum  427  (51.9)  
Colonoscopy indication,  n  (%)
Diagnostic  489  (59.5)  
Screening  250  (30.4)  
Follow-up 83  (10.1)  
Presence of  distal  AN,  n  %  52  (6.3)  
AN: advanced neoplasia; PAN: proximal advanced neoplasia; SD: standa
a Chi-square test with the Yates correction.
b Fisher exact test.
c Pearson chi-square test.
d Mann-Whitney U test.V.  Parra-Pérez  et  al.
re  associated  with  reduced  colorectal  cancer  mortality,9
ut  detection  and  removal  of  adenomas,  especially  those
hat  are  advanced,  are  also  associated  with  reduced  colo-
ectal  cancer  incidence.41,42
Age  and  sex  were  found  to  be  important  risk  factors
or  the  development  of  advanced  colorectal  neoplasia.  Men
ave  almost  double  the  risk  for  developing  advanced  neo-
lasia,  compared  with  women.  There  was  also  a  signiﬁcant
ation  N  =  822  PAN
Yes  No  p
63,29  ±  11.93  56.96  ±  14.77  0.003d
0.047c
2  (3.6)  99  (12.9)
4  (7.3)  132  (17.2)
15  (27.3)  180  (23.5)
19  (34.5)  189  (24.6)
15  (27.3)  167  (21.8)
31  (56.4)  501  (65.3)  0.231a
24  (43.6)  266  (34.7)
26.56  ±  3.82  25.98  ±  4.01  0.243a
8  (14.5)  106  (13.8)  1.00a
47  (85.5)  661  (86.2)
21  (38.2)  321  (48.9)  0.695a
34  (61.8)  446  (51.1)
26  (47.3)  291  (37.9)  0.219a
9  (16.4)  91  (11.9)  0.440a
23  (41.8)  261  (34.0)  0.305a
11  (20.0)  98  (12.8)  0.187a
4  (7.3)  54  (7.0)  1.000b
2  (3.6)  64  (8.3)  0.381c
9  (16.4)  144  (18.8)
44  (80.0)  559  (72.9)
51  (92.7)  699  (91.1)  1.000b
4  (7.3)  68  (8.9)
26  (47.3)  369  (48.1)  1.000a
29  (52.7)  398  (51.9)
30  (54.5)  459  (59.8)  0.120c
15  (27.3)  235  (30.6)
10  (18.2)  73  (9.5)
8  (14.5)  44  (5.7)  0.018b
rd deviation.
Factors  related  to  advanced  colorectal  neoplasm  at  the  Policlíni
Table  6  Factors  related  to  the  multivariate  analysis-PAN.
OR  95%  CI  p
Age,  years
<  40  1.000  -  -
40-49 1.486  0.267-8.287  0.651
50-59 3.920  0.876-17.533  0.074
60-69 4.762  1.085-20.903  0.039
≥ 70  4.143  0.925-18.565  0.063
Presence  of  distal  AN  2.499  0.742-3.884  0.028
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The  authors  declare  that  there  is  no  conﬂict  of  interest.AN: advanced neoplasia; PAN: proximal advanced neoplasia.
association  between  age  and  advanced  neoplasia.  Patients
above  the  age  of  70  years,  in  particular,  have  a  4-fold
greater  risk  compared  with  those  under  40  years  of  age.
Greater  colorectal  neoplasia  prevalence  associated  with
age  has  been  observed  in  previous  studies.13,26 Other  fac-
tors,  such  as  a  family  history  of  colorectal  cancer,  tobacco
smoking,  and  BMI  were  not  related  to  advanced  colorectal
neoplasia  in  our  study,  unlike  that  reported  by  Kaminski
et  al. 9
Flexible  sigmoidoscopy  is  generally  well-tolerated,  easy
to  perform,  safe  and  economic.16 Thus,  sigmoidoscopy  is
an  adequate  initial  large-scale  screening  test  for  colorec-
tal  cancer.  Nevertheless,  sigmoidoscopy  cannot  evaluate
the  proximal  colon  and  therefore  studies  have  been  con-
ducted  to  identify  factors  related  to  proximal  neoplasia  that
could  be  used  to  identify  patients  that  would  need  com-
plementary  colonoscopy.  Findings  in  the  distal  colon  (large
neoplasms  or  histologically  advanced  neoplasia)  have  been
identiﬁed  as  risk  factors  for  PAN,  along  with  some  clinical
characteristics  (age,  male  sex,  obesity,  alcohol  ingestion
or  tobacco  smoking,  and  a  family  history  of  colorectal
cancer).21--23,27,29--33,37
We  also  evaluated  factors  related  to  PAN.  For  that  anal-
ysis,  only  the  colonoscopies  in  which  cecal  intubation  was
achieved  were  taken  into  account.31 Age  and  the  presence
of  distal  AN  were  found  to  be  related,  but  not  sex.  In  regard
to  age,  it  was  preferable  for  initial  colonoscopy  to  be  per-
formed,  rather  than  sigmoidoscopy,  in  patients  above  the
age  of  60  years,  due  to  the  high  risk  for  ﬁnding  PAN  in  that
group  of  patients.  With  respect  to  distal  AN,  there  was  a
2.5-fold  increased  risk.  This  concurred  with  the  ﬁndings  of
Leung  et  al.,31 who  found  a  3.9-fold  risk  increase  in  that
group  of  patients.  Other  ﬁndings  in  the  distal  colon,  such  as
non-advanced  neoplasias,  were  not  statistically  signiﬁcant
in  relation  to  PAN,  which  perhaps  was  due  to  the  small  size
of  our  study  sample.
In  the  present  study,  6.1%  of  the  patients  with  no  neo-
plasia  in  the  distal  colon  presented  with  PAN.  Alternatively,
76.4%  of  the  patients  with  proximal  advanced  lesion  had
no  neoplasia  in  the  distal  colon.  These  results  are  related
to  those  of  previous  reports.13,22,29,31,32 It  can  be  deduced
from  these  ﬁndings  that  three-quarters  of  advanced  colonic
lesions  could  be  missed  in  sigmoidoscopy,  if  colonoscopy
were  not  performed  in  patients  presenting  with  no  neoplasia
in  the  distal  colon.
Our  deﬁnition  of  AN  was  the  same  as  that  used  in
the  majority  of  the  previous  studies,  and  it  included
adenomas  >  1  cm.5,9,13,25,26,29--31,33,37 Given  that  polyp  size
A
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etermination  can  be  subject  to  wide  interobserver  vari-
bility,  a more  rigorous  deﬁnition  without  considering
ize,  such  as  that  proposed  by  Imperiale  et  al.,22 could
revent  such  a  discrepancy.  Therefore  our  AN  detec-
ion  rate  can  be  different,  when  compared  with  that  of
mperiale.
Among  the  limitations  of  our  study  is the  small  sam-
le  size.  This  was  probably  the  reason  that  no  other
isk  factors  for  advanced  neoplasia  were  identiﬁed,  such
s  a  family  history  of  colon  cancer,  tobacco  smoking,
besity,  and  diabetes  mellitus.  Furthermore,  we  did  not
ake  other  risk  factors  into  account,  such  as  aspirin  use.
ikewise,  our  risk  factors  only  predicted  advanced  neo-
lasia  detection  at  the  time  of  evaluation,  and  not  the
uture  risk  for  developing  advanced  colorectal  neoplasia
r  death  from  colorectal  cancer.  In  addition,  like  Dodou
nd  Winter24 and  Chung  et  al.,25 we  considered  both
ymptomatic  and  asymptomatic  patients,  which  can  dis-
ort  the  comparisons  with  other  studies  that  only  evaluated
atients  for  screening5--9,13,21--23,29,30,33,37 or  symptomatic
atients.31,36
In  conclusion,  our  study  found  that  age  and  sex  were
elated  to  the  presence  of  advanced  colorectal  neoplasia,
nd  that  age  and  distal  AN  were  related  to  PAN.  In  particu-
ar,  patients  above  the  age  of  60  years  would  require  initial
olonoscopy,  as  opposed  to  sigmoidoscopy  for  colon  evalu-
tion.  Future  studies  with  larger  samples  are  necessary  in
rder  to  ﬁnd  other  related  factors  and  to  establish  a  score
or  identifying  individuals  at  high  risk  for  presenting  with
dvanced  colorectal  neoplasia.
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